Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 23 - Anaesthetics
Patents for A61P 23 - Anaesthetics (4,141)
05/2000
05/11/2000DE19851605A1 Mikropartikel enthaltendes Injektionsanästhesiemittel A microparticle-containing injectable anesthetic composition
05/11/2000DE19851604A1 Injektionsanästhesiemittel mit hydrophiler Phase Injectable anesthetic agent with hydrophilic phase
05/10/2000EP0998288A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
05/10/2000EP0998287A2 Use of levobupivacaine
05/10/2000EP0998286A2 Use of levobupivacaine
05/10/2000CN1252725A Analgesic combination
05/09/2000US6060085 Dissolved drug that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a drug in a microparticulate state that does not readily cross the stratum corneum
05/04/2000WO2000024376A1 Propofol composition
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0743940B1 New compounds with analgesic and local anaesthetic effect
05/03/2000CN1052004C Heterocyclic compounds, their production and use
04/2000
04/27/2000WO2000023050A1 Propofol composition comprising pentetate
04/27/2000CA2347118A1 Propofol composition comprising pentetate
04/20/2000WO2000021520A2 Opioid analgesic
04/19/2000EP0738262B1 Novel heterocyclic compounds
04/18/2000US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions
04/12/2000EP0991405A1 Clear, injectable formulation of an anesthetic compound
04/06/2000WO2000018400A1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
04/06/2000WO2000018369A1 Iontophoretic devices comprising piperidin derivatives
04/05/2000CN1249684A Use of levobupivacaine in facial surgery
04/05/2000CN1249683A Use of leveobupivacaine in paediatric surgery
04/04/2000US6046187 Use of glucocorticosteroids in methods and formulations for prolonging and/or reactivating local anesthesia or local anesthesia previously induced by a local anesthetic agent
04/04/2000US6045824 Sustained-release liposomal anesthetic compositions
03/2000
03/29/2000EP0987942A1 Pharmaceutical composition and methods for using it
03/28/2000US6043240 Useful as antipsychotic and analgesic agents
03/28/2000US6043239 Heterocyclic compounds
03/23/2000WO2000015167A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions
03/23/2000CA2343223A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions
03/22/2000EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
03/22/2000CN1247741A Emulsified inhalational anaesthetic for intravenous injection and its preparation
03/15/2000CN1050283C Gel-type cosmetic composite
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/02/2000WO2000010531A1 Injectable aqueous dispersions of propofol
03/02/2000WO2000010529A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010528A1 Oral liquid mucoadhesive compositions
03/01/2000EP0982297A2 Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists
03/01/2000EP0981348A1 The use of levobupivacaine in paediatric surgery
03/01/2000EP0981347A1 The use of levobupivacaine in facial surgery
03/01/2000CN1245799A Preparation method of pyrrolidyl hydroxamic acid compound
02/2000
02/29/2000US6031114 Process for pyrrolidinyl hydroxamic acid compounds
02/29/2000US6031007 A homogenous dental emulsion or microemulsion of local anesthetic in oil form, a surfactant having thermoreversible gelling properties, i.e. thickening when contacting mucous membranes, and water; pathological periodontal pockets; scale
02/24/2000WO2000009089A1 Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
02/24/2000CA2277242A1 Process for pyrrolidinyl hydroxamic acid compounds
02/22/2000US6028108 Propofol composition comprising pentetate
02/22/2000US6028068 Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
02/17/2000WO2000007986A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments
02/16/2000EP0979087A1 Analgesic combination
02/16/2000CN1244797A Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
02/16/2000CN1244391A Long-acting analgesic used mainly for operational cut and traumatic wound
02/10/2000WO2000006142A1 Injectable propofol formulations
02/03/2000WO2000005196A1 α-AMINO ACID PHENYL ESTER DERIVATIVES
02/03/2000DE19834714A1 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 2,3,3a, 4,9,9a-hexahydro-8-hydroxy-1H-ben [f] indoles, to processes for their preparation and their use as medicaments
02/03/2000CA2337945A1 .alpha.-amino acid phenyl ester derivatives
02/02/2000EP0975599A1 Subtituted isoquinolines as ultra short acting neuromuscular blockers
01/2000
01/27/2000WO2000003716A1 Topical compositions comprising an opioid analgesic and an nmda antagonist
01/27/2000WO2000003691A1 Systems and methods for local delivery of an agent
01/26/2000EP0973741A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist
01/19/2000EP0971898A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
01/13/2000WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
01/12/2000EP0862566B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
01/05/2000EP0967975A1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
01/05/2000CN1240353A Local anesthetic for external use
01/05/2000CN1240132A Controlled release formulation
12/1999
12/29/1999EP0966304A1 Site-specific drug delivery
12/29/1999EP0677514B1 Cyclopropyl derivatives, preparation method thereof and applications
12/15/1999EP0963202A1 Formulations and methods for providing prolonged local anesthesia
12/14/1999US6001834 [(4-heteroaryl-1-piperazinyl)alkoxy]-3,4-dihydro-1(2h)-naphthalenones and related compounds and their therapeutic utility
12/08/1999CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
12/08/1999CN1237907A Formulation for electrically assisted delivery of lidocaine and epinephrine
12/07/1999US5998417 N-[(4-heteroaryl-1-piperazinyl) alkyl]phthalimides and related compounds and their therapeutic utility
12/02/1999WO1999061023A1 Cocaine receptor binding ligands
12/02/1999WO1999051565A9 Novel local anesthetic compounds and uses
11/1999
11/30/1999US5993841 Treating or disorder of the nervous system comprising topically applying an antibiotic; an antihistamine; and a carrier; wherein said antibiotic and said antihistamine are present in relative amounts of 30:70 to 70:30% by weight
11/25/1999WO1999059553A1 Effervescent preparations
11/24/1999EP0957906A1 Local anesthetic for external use
11/24/1999EP0957900A1 Compositions and methods for topical application of therapeutic agents
11/23/1999US5990176 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/17/1999EP0956026A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
11/11/1999WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology
11/11/1999WO1999056725A1 Pharmaceutical compositions capable of being gelled
11/10/1999EP0954301A1 Methods for providing safe local anesthesia
11/10/1999EP0954278A1 Pharmaceutical compositions containing kukui nut oil
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/02/1999US5977140 N-[(4-Heteroaryl-1-Piperidinyl)Alkly] Phthalimides and related compounds and their therapeutic utility
11/02/1999US5977113 4-heteroaryl-1-piperazine alkylamines and their therapeutic utility
10/1999
10/27/1999EP0167575B2 Cardiodilatine, a peptide hormone and production process thereof
10/26/1999US5972932 Olanzapine or a salt or solvate thereof, and an opoid in a specific weight ratio; administering to provide mild pre-surgical anesthesia to provide amnesia while maintaining cooperation in mammals such as humans
10/21/1999WO1999039712A9 Substituted semicarbazides and the use thereof
10/19/1999US5968953 For side effect reduction
10/14/1999WO1999051565A1 Novel local anesthetic compounds and uses
10/14/1999CA2315946A1 Novel local anesthetic compounds and uses
10/12/1999US5965546 1-[(2-pyrimidinyloxy)alkyl]4-(heteroaryl)piperazines and related compounds and their therapeutic utility
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/05/1999US5962536 Injectable propofol formulations
10/05/1999US5962532 Therapeutic method with capsaicin and capsaicin analogues
09/1999
09/28/1999CA2133503C Orally administrable opioid formulations having extended duration of effect
09/21/1999US5955098 C 3-8 linear or branched hydrocarbon propellant
09/15/1999EP0941085A2 Formulation for electrically assisted delivery of lidocaine and epinephrine
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42